MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
Institute Catalá Oncología
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institute Catalá Oncología (7)
2021
-
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938
2013
-
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)
Medical Mycology, Vol. 51, Núm. 2, pp. 150-154
2012
2003
2002
-
CsA-based post-graft immunosuppression: The main factor for improving outcome of allografted patients with acquired aplastic anemia: A retrospective survey by the Spanish Group of Hematopoietic Transplantation
Bone Marrow Transplantation, Vol. 29, Núm. 3, pp. 205-211
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886
2001
-
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: The role of preparative regimens
Bone Marrow Transplantation, Vol. 27, Núm. 4, pp. 405-412